News tagged with statins
Research reveals possible reason for cholesterol-drug side effects
The U.S. Food and Drug Administration and physicians continue to document that some patients experience fuzzy thinking and memory loss while taking statins, a class of global top-selling cholesterol-lowering ...
Medical research
May 10, 2013 |
4.5 / 5 (11) |
13
|
Cholesterol drugs might boost kidney cancer survival
(HealthDay)—Cholesterol-lowering statin drugs that are taken by millions of Americans might also improve survival from a type of kidney cancer called renal cell carcinoma, a new study suggests.
Cancer
May 07, 2013 |
5 / 5 (1) |
0
Risk of new-onset diabetes varies with different statins
(HealthDay)—Different types and doses of statins seem to correlate with distinct risks of developing new-onset diabetes mellitus (DM), according to a meta-analysis published in the April 15 issue of The Am ...
Cancer
Apr 11, 2013 |
not rated yet |
0
Co-Q10 deficiency may relate to concern with statin drugs, higher risk of diabetes
(Medical Xpress)—A laboratory study has shown for the first time that coenzyme Q10 offsets the cellular changes that are linked to a side-effect of some statin drugs - an increased risk of adult-onset diabetes.
Diseases, Conditions, Syndromes
Apr 10, 2013 |
4 / 5 (1) |
0
|
High potency statins pose significantly higher risk of kidney injury than low potency, say experts
Patients taking high potency statins for high blood pressure are at a 34% higher risk of being hospitalised for acute kidney injury (AKI), compared with those taking low potency statins, a paper published today in BMJ sugges ...
Cardiology
Mar 19, 2013 |
5 / 5 (1) |
1
Cardio risks need evaluation before prescribing statins
(HealthDay)—Physicians may not adequately consider a patient's cardiovascular risk when prescribing statins as preventive therapy, according to a research letter published online March 11 in JAMA Internal Me ...
Cardiology
Mar 15, 2013 |
3 / 5 (1) |
0
Study: Mega vitamins won't help after heart attack, chelation treatment might
(HealthDay)—There's mixed news from a much-anticipated clinical trial for people who've suffered a heart attack: While a study found that daily high doses of vitamins and minerals did nothing to improve ...
Cardiology
Mar 11, 2013 |
1 / 5 (1) |
0
|
Drug protects against kidney injury from imaging dye in ACS patients
High doses of a popular cholesterol-lowering drug significantly reduced the rate of acute kidney injury caused by dye used in imaging in acute coronary syndrome patients who underwent a coronary procedure, according to research ...
Cardiology
Mar 11, 2013 |
not rated yet |
0
ACC: Stressful events up incidence of acute MI
(HealthDay)—Stressful events, including hurricanes, earthquakes, and financial crises, correlate with increased incidence of acute myocardial infarction (AMI), according to three studies to be presented ...
Cardiology
Mar 08, 2013 |
not rated yet |
0
The side effects of statin ads
Television advertising may drive over-diagnosis of high cholesterol and over-treatment with statins, according to a new study by Dr. Jeff Niederdeppe from Cornell University in the US and colleagues. It appears that a trip ...
Cardiology
Mar 07, 2013 |
not rated yet |
0
Statin use linked to reduced risk of hepatocellular cancer
(HealthDay)—Statin use is associated with a reduced risk of hepatocellular carcinoma (HCC), most strongly in Asian populations, according to a meta-analysis published in the February issue of Gastroenterology.
Cancer
Feb 12, 2013 |
not rated yet |
0
Merck warns doctors to stop prescribing Tredaptive
Drugmaker Merck says it is suspending its sale of the cholesterol drug Tredaptive and is telling doctors to quit prescribing the medicine.
Medications
Jan 11, 2013 |
1 / 5 (1) |
0
Cholesterol medicine affects energy production in muscles
Up to 75 per cent of patients who take statins to treat elevated cholesterol levels may suffer from muscle pain. Scientists at the Center for Healthy Aging at the University of Copenhagen have now identified ...
Cardiology
Jan 03, 2013 |
5 / 5 (2) |
0
Open-angle glaucoma up 22 percent in last 10 years
(HealthDay)—The prevalence of open-angle glaucoma has increased more than 20 percent in the last 10 years and currently affects more than 2.7 million Americans age 40 years and older, according to a report ...
Ophthalmology
Jan 01, 2013 |
5 / 5 (1) |
0
Statins plus exercise best at lowering cholesterol, study finds
(HealthDay)—People who exercise along with taking statins to lower their high cholesterol levels can dramatically reduce their risk of dying, a large new study suggests.
Cardiology
Nov 28, 2012 |
not rated yet |
1
|
Statin
The statins (or HMG-CoA reductase inhibitors) are a class of drugs that lower cholesterol levels in people with or at risk of cardiovascular disease.
They lower cholesterol by inhibiting the enzyme HMG-CoA reductase, which is the rate-limiting enzyme of the mevalonate pathway of cholesterol synthesis. Inhibition of this enzyme in the liver results in decreased cholesterol synthesis as well as increased synthesis of LDL receptors, resulting in an increased clearance of low-density lipoprotein (LDL) from the bloodstream. The first results can be seen after one week of use and the effect is maximal after four to six weeks.
For more information about Statin, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
